© The Global Fund/Andrew Esiebo
After years of remarkable progress in the fight against HIV, tuberculosis, and malaria, new threats have pushed countries off track. Shortfalls in funding and increasing drug resistance have slowed progress and enabled the diseases to gain ground, undermining efforts to reach the Sustainable Development Goal target of ending the epidemics by 2030. Nearly 1,000 adolescent girls and young women globally are infected with HIV every day. A child still dies of malaria every two minutes. And TB is now the world’s deadliest infectious disease.
Partner: The Global Fund to Fight AIDS, Tuberculosis and Malaria
Budget: 1 billion yen
Term: 5 years
The renewal of Takeda’s partnership with the Global Fund builds on the company's first financial pledge to the Global Fund (Takeda Initiative 1), which focused on strengthening the capacity of health care workers in Africa. The Takeda Initiative 2 aims to improve maternal and child health by integrating quality HIV, TB, and malaria services in antenatal and postnatal care in several priority countries in Africa. By providing more pregnant women with better quality care, and reducing the cost of interventions, countries will be closer to achieving universal health coverage.